Heba E. Hashem

1.1k total citations
30 papers, 758 citations indexed

About

Heba E. Hashem is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Heba E. Hashem has authored 30 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Organic Chemistry, 5 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Heba E. Hashem's work include Synthesis and biological activity (17 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers) and Synthesis and Biological Evaluation (6 papers). Heba E. Hashem is often cited by papers focused on Synthesis and biological activity (17 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers) and Synthesis and Biological Evaluation (6 papers). Heba E. Hashem collaborates with scholars based in Egypt, Pakistan and Russia. Heba E. Hashem's co-authors include Eman M. Azmy, Eslam A. Mohamed, Nabel A. Negm, Youness El Bakri, Ahmed A. Farag, Ajoy Kumer, Eman S. Nossier, Abd El‐Galil E. Amr, Ahmed S. A. Youssef and Elsayed A. Elsayed and has published in prestigious journals such as Scientific Reports, Molecules and Journal of Molecular Liquids.

In The Last Decade

Heba E. Hashem

30 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heba E. Hashem Egypt 16 486 133 110 106 69 30 758
Abdulrahman G. Alhamzani Saudi Arabia 13 219 0.5× 80 0.6× 58 0.5× 92 0.9× 55 0.8× 58 537
Fawzia Faleh Al-blewi Saudi Arabia 19 755 1.6× 166 1.2× 69 0.6× 111 1.0× 63 0.9× 28 973
Ahmed F. El‐Farargy Egypt 15 571 1.2× 119 0.9× 64 0.6× 93 0.9× 42 0.6× 55 817
Moustafa S. Abusaif Egypt 20 475 1.0× 189 1.4× 52 0.5× 133 1.3× 45 0.7× 46 871
Youssef Kandri Rodi Morocco 12 352 0.7× 106 0.8× 40 0.4× 126 1.2× 37 0.5× 125 568
Mohammed H. Geesi Saudi Arabia 17 426 0.9× 175 1.3× 46 0.4× 181 1.7× 93 1.3× 75 837
Faiz A. Al‐aizari Saudi Arabia 11 762 1.6× 105 0.8× 64 0.6× 61 0.6× 84 1.2× 20 976
Mohammed Issa Alahmdi Saudi Arabia 15 383 0.8× 147 1.1× 31 0.3× 104 1.0× 79 1.1× 55 648
Faizah S. Aljohani Saudi Arabia 16 639 1.3× 105 0.8× 481 4.4× 161 1.5× 122 1.8× 25 930
Manal M. Khowdiary Saudi Arabia 15 200 0.4× 88 0.7× 18 0.2× 106 1.0× 36 0.5× 40 489

Countries citing papers authored by Heba E. Hashem

Since Specialization
Citations

This map shows the geographic impact of Heba E. Hashem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba E. Hashem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba E. Hashem more than expected).

Fields of papers citing papers by Heba E. Hashem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba E. Hashem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba E. Hashem. The network helps show where Heba E. Hashem may publish in the future.

Co-authorship network of co-authors of Heba E. Hashem

This figure shows the co-authorship network connecting the top 25 collaborators of Heba E. Hashem. A scholar is included among the top collaborators of Heba E. Hashem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba E. Hashem. Heba E. Hashem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hashem, Heba E., Sajjad Ahmad, Ajoy Kumer, & Youness El Bakri. (2024). In silico and in vitro prediction of new synthesized N-heterocyclic compounds as anti-SARS-CoV-2. Scientific Reports. 14(1). 1152–1152. 22 indexed citations
2.
Hashem, Heba E., Abd El‐Galil E. Amr, Abdulrahman A. Almehizia, et al.. (2023). Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and CDK-2 Inhibitors: Design, Structure Determination, Anticancer Evaluation and In Silico Studies. Molecules. 28(21). 7252–7252. 11 indexed citations
3.
Hashem, Heba E., Abd El‐Galil E. Amr, Eman S. Nossier, Manal M. Anwar, & Eman M. Azmy. (2022). New Benzimidazole-, 1,2,4-Triazole-, and 1,3,5-Triazine-Based Derivatives as Potential EGFRWT and EGFRT790M Inhibitors: Microwave-Assisted Synthesis, Anticancer Evaluation, and Molecular Docking Study. ACS Omega. 7(8). 7155–7171. 60 indexed citations
4.
Bakri, Youness El, et al.. (2022). Self-assembly of new cobalt complexes based on [Co (SCN)4], synthesis, empirical, antioxidant activity, and quantum theory investigations. Scientific Reports. 12(1). 15828–15828. 23 indexed citations
5.
Azeem, Muhammad, Muhammad Hanif, Khalid Mahmood, et al.. (2022). Design, synthesis, spectroscopic characterization, in-vitro antibacterial evaluation and in-silico analysis of polycaprolactone containing chitosan-quercetin microspheres. Journal of Biomolecular Structure and Dynamics. 41(15). 7084–7103. 11 indexed citations
6.
Hashem, Heba E., et al.. (2022). Comprehensive review on the Bis–heterocyclic compounds and their anticancer efficacy. Journal of Molecular Structure. 1271. 133970–133970. 67 indexed citations
7.
Hashem, Heba E. & Youness El Bakri. (2021). An overview on novel synthetic approaches and medicinal applications of benzimidazole compounds. Arabian Journal of Chemistry. 14(11). 103418–103418. 44 indexed citations
8.
Siddique, Farhan, et al.. (2021). Analysis and prediction pathways of natural products and their cytotoxicity against HeLa cell line protein using docking, molecular dynamics and ADMET. Journal of Biomolecular Structure and Dynamics. 41(3). 765–777. 29 indexed citations
9.
Hashem, Heba E., Eslam A. Mohamed, Ahmed A. Farag, Nabel A. Negm, & Eman M. Azmy. (2021). New heterocyclic Schiff base‐metal complex: Synthesis, characterization, density functional theory study, and antimicrobial evaluation. Applied Organometallic Chemistry. 35(9). 68 indexed citations
10.
Mohamed, Eslam A., Heba E. Hashem, Eman M. Azmy, Nabel A. Negm, & Ahmed A. Farag. (2021). Synthesis, structural analysis, and inhibition approach of novel eco-friendly chalcone derivatives on API X65 steel corrosion in acidic media assessment with DFT & MD studies. Environmental Technology & Innovation. 24. 101966–101966. 40 indexed citations
11.
Altalhi, Amal A., Heba E. Hashem, Nabel A. Negm, Eslam A. Mohamed, & Eman M. Azmy. (2021). Synthesis, characterization, computational study, and screening of novel 1-phenyl-4-(2-phenylacetyl)-thiosemicarbazide derivatives for their antioxidant and antimicrobial activities. Journal of Molecular Liquids. 333. 115977–115977. 17 indexed citations
12.
Hashem, Heba E.. (2021). A Short Review on the Synthesis of 1,2,4-Triazine Derivatives as Bioactive Compounds. Mini-Reviews in Organic Chemistry. 18(8). 1127–1133. 15 indexed citations
13.
Hashem, Heba E., Abd El‐Galil E. Amr, Eman S. Nossier, Elsayed A. Elsayed, & Eman M. Azmy. (2020). Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors. Molecules. 25(12). 2766–2766. 60 indexed citations
14.
Hashem, Heba E., et al.. (2020). Advancements in synthesis of pharmacologically active imidazolidin‐4‐ones and stereochemistry of their Reactions with some Reagents. Journal of Heterocyclic Chemistry. 57(3). 1344–1360. 3 indexed citations
15.
Hashem, Heba E.. (2020). IN Silico Approach of Some Selected Honey Constituents as SARS-CoV-2 Main Protease (COVID-19) Inhibitors. Eurasian Journal of Medicine and Oncology. 28 indexed citations
16.
Hashem, Heba E., et al.. (2019). New 1,3,4‐Thiadiazole Derivatives: Synthesis, Characterization, and Antimicrobial Activity. Journal of Heterocyclic Chemistry. 56(3). 1038–1047. 14 indexed citations
17.
Hashem, Heba E., et al.. (2019). Synthesis and reactions of 4H-3,1-benzoxazin-4-one derivative bearing pyrazolyl moiety as antimicrobial and antioxidant agents. Synthetic Communications. 1–16. 7 indexed citations
18.
Azmy, Eman M., Heba E. Hashem, Eslam A. Mohamed, & Nabel A. Negm. (2019). Synthesis, characterization, swelling and antimicrobial efficacies of chemically modified chitosan biopolymer. Journal of Molecular Liquids. 284. 748–754. 52 indexed citations
19.
Hashem, Heba E., et al.. (2019). Synthesis of Some New 1,2,4-Triazine and 1,2,5-Oxadiazine Derivatives with Antimicrobial Activity. Heteroatom Chemistry. 2019. 1–7. 15 indexed citations
20.
Youssef, Ahmed S. A., et al.. (2018). Reaction of 2‐Phenyl‐4‐arylidene‐1,3‐oxazolones with Different Nucleophiles for Synthesis of Some New Heterocycles. Journal of Heterocyclic Chemistry. 56(2). 456–463. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026